Product, Therapy & Care Guides
Step-by-step guides for product use, therapy planning, veterinary conversations, monitoring, surgery recovery, chemotherapy support, comfort care, and long-term observation. Guides answer what to do next; Directory entries explain what each product, drug, herb, or therapy is.

Palladia Companion Guide: Safe Home Handling and Monitoring
Handle intact tablets as a hazardous antineoplastic, record every dose and gastrointestinal or mobility change, complete scheduled exams and laboratory tests, and obey stop-and-call instructions.
Read more
Laverdia Companion Guide: Prescription, Handling, and Home Monitoring
Give only the prescribed intact tablets immediately after food, keep doses at the instructed interval, use chemotherapy gloves and three-day waste precautions, and report adverse changes early.
Read more
Targeted Cancer Medicine Safety: A Shared Monitoring Plan
Targeted does not mean side-effect free. The prescribing veterinarian and current product labeling determine dose, schedule, handling, drug interactions, laboratory testing, and whether to hold a dose; this…
Read more
Targeted Therapy: Blood Pressure, Urine, and Laboratory Monitoring Map
Turn the prescriber’s safety plan into one calendar and distinguish clinic measurements from home observations without changing treatment independently.
Read more
Palliative Crisis Plan: Prepare the Home-to-Hospital Handoff
Name likely crises, define home observations and limits, identify emergency and euthanasia pathways, prepare transport, and make decisions before distress narrows the available choices.
Read more
Planning a Peaceful Euthanasia Conversation Before a Crisis
Use observed quality-of-life trends and the veterinarian’s medical assessment to define unacceptable suffering, practical options, and a compassionate plan without presenting a score as an automatic decision.
Read more
Treatment Estimate Conversation: Compare Scope, Not Just Totals
Ask each estimate to show its clinical goal, included services, likely extras, decision points, follow-up, complications, payment timing, and lower-burden alternatives without equating price with outcome.
Read more